{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:03:06Z","timestamp":1790100186461,"version":"4.0.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372004,81871382, 82150610508"],"award-info":[{"award-number":["82372004,81871382, 82150610508"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08602-x","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T22:43:12Z","timestamp":1754692992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Resynchronization of microglial activity in the brain is associated with restoration of motor function in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"8","author":[{"given":"Peizhen","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1522-1098","authenticated-orcid":false,"given":"Hongjun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"8602_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"GBD 2016 Parkinson\u2019s Disease Collaborators","year":"2018","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 17, 939\u2013953 (2018).","journal-title":"Lancet Neurol."},{"key":"8602_CR2","doi-asserted-by":"publisher","first-page":"a009258","DOI":"10.1101\/cshperspect.a009258","volume":"2","author":"DW Dickson","year":"2012","unstructured":"Dickson, D. W. Parkinson\u2019s disease and parkinsonism: neuropathology. Cold Spring Harb. Perspect. Med. 2, a009258 (2012).","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"8602_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic, J. Parkinson\u2019s disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79, 368\u2013376 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"8602_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/ph14090847","volume":"14","author":"\u0160 Korat","year":"2021","unstructured":"Korat, \u0160 et al. Alpha-synuclein PET tracer development-an overview about current efforts. Pharmaceuticals. 14, 847 (2021).","journal-title":"Pharmaceuticals"},{"key":"8602_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/ana.10513","volume":"53","author":"O Rascol","year":"2003","unstructured":"Rascol, O. et al. Limitations of current Parkinson\u2019s disease therapy. Ann. Neurol. 53, S3\u2013S12 (2003).","journal-title":"Ann. Neurol."},{"key":"8602_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/1073858421991066","volume":"28","author":"T Wang","year":"2022","unstructured":"Wang, T. et al. Neuroinflammation in Parkinson\u2019s disease: triggers, mechanisms, and immunotherapies. Neuroscientist 28, 364\u2013381 (2022).","journal-title":"Neuroscientist"},{"key":"8602_CR7","doi-asserted-by":"publisher","first-page":"103484","DOI":"10.1016\/j.autrev.2023.103484","volume":"23","author":"JS Lee","year":"2024","unstructured":"Lee, J. S., Sato, W. & Son, C. G. Brain-regional characteristics and neuroinflammation in ME\/CFS patients from neuroimaging: a systematic review and meta-analysis. Autoimmun. Rev. 23, 103484 (2024).","journal-title":"Autoimmun. Rev."},{"key":"8602_CR8","doi-asserted-by":"crossref","unstructured":"Gullett, Joseph M. Neuroinflammation in encyclopedia of gerontology and population aging (eds Gu, Danan & Dupre, Matthew E.) 1\u20136 (Springer International Publishing, Cham, 2019).","DOI":"10.1007\/978-3-319-69892-2_675-1"},{"key":"8602_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng, F. & Edison, P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?. Nat. Rev. Neurol. 17, 157\u2013172 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"8602_CR10","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/s41380-024-02464-1","volume":"29","author":"L Liu","year":"2024","unstructured":"Liu, L. et al. Running exercise alleviates hippocampal neuroinflammation and shifts the balance of microglial M1\/M2 polarization through adiponectin\/AdipoR1 pathway activation in mice exposed to chronic unpredictable stress. Mol. Psychiatry 29, 2031\u20132042 (2024).","journal-title":"Mol. Psychiatry"},{"key":"8602_CR11","doi-asserted-by":"publisher","first-page":"105094","DOI":"10.1016\/j.neuint.2021.105094","volume":"148","author":"T Zheng","year":"2021","unstructured":"Zheng, T. & Zhang, Z. Activated microglia facilitate the transmission of \u03b1-synuclein in Parkinson\u2019s disease. Neurochem. Int. 148, 105094 (2021).","journal-title":"Neurochem. Int."},{"key":"8602_CR12","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.2147\/DDDT.S210511","volume":"13","author":"Y Bao","year":"2019","unstructured":"Bao, Y. et al. Dexmedetomidine attenuates neuroinflammation in LPS-stimulated BV2 microglia cells through upregulation of miR-340. Drug Des. Dev. Ther. 13, 3465\u20133475 (2019).","journal-title":"Drug Des. Dev. Ther."},{"key":"8602_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jneuroim.2011.06.017","volume":"238","author":"C Pintado","year":"2011","unstructured":"Pintado, C. et al. Regional difference in inflammatory response to LPS-injection in the brain: role of microglia cell density. J. Neuroimmunol. 238, 44\u201351 (2011).","journal-title":"J. Neuroimmunol."},{"key":"8602_CR14","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/glia.20677","volume":"56","author":"KA Ji","year":"2008","unstructured":"Ji, K. A. et al. Differential neutrophil infiltration contributes to regional differences in brain inflammation in the substantia nigra pars compacta and cortex. Glia 56, 1039\u20131047 (2008).","journal-title":"Glia"},{"key":"8602_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1536012118792317","volume":"17","author":"V Narayanaswami","year":"2018","unstructured":"Narayanaswami, V. et al. Emerging PET radiotracers and targets for imaging of neuroinflammation in neurodegenerative diseases: outlook beyond TSPO. Mol. Imaging 17, 1\u201325 (2018).","journal-title":"Mol. Imaging"},{"key":"8602_CR16","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1002\/brx2.55","volume":"2","author":"Y Qiu","year":"2024","unstructured":"Qiu, Y. et al. Positron emission tomography imaging of the P2X7 receptor with a novel tracer, [18F]GSK1482160, in a transgenic mouse model of Alzheimer\u2019s disease and healthy non-human primates. Brain-X 2, e55 (2024).","journal-title":"Brain-X"},{"key":"8602_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2017.12.006","volume":"820","author":"H Jin","year":"2018","unstructured":"Jin, H. et al. Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease. Eur. J. Pharm. 820, 8\u201317 (2018).","journal-title":"Eur. J. Pharm."},{"key":"8602_CR18","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1158\/1078-0432.CCR-24-2830","volume":"31","author":"W Zhou","year":"2025","unstructured":"Zhou, W. et al. Visualization of P2X7 receptors in living human gliomas: an 18F-GSK1482160 PET imaging and neuropathology study. Clin. Cancer Res. 31, 2183\u20132195 (2025).","journal-title":"Clin. Cancer Res"},{"key":"8602_CR19","first-page":"214714","volume":"2012","author":"PF Durrenberger","year":"2012","unstructured":"Durrenberger, P. F. et al. Inflammatory pathways in Parkinson\u2019s disease; A BNE Microarray Study. Parkinsons Dis. 2012, 214714 (2012).","journal-title":"Parkinsons Dis."},{"key":"8602_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fncel.2019.00476","volume":"13","author":"\u00c1 Oliveira-Giacomelli","year":"2019","unstructured":"Oliveira-Giacomelli, \u00c1 et al. P2Y6 and P2X7 receptor antagonism exerts neuroprotective\/ neuroregenerative effects in an animal model of Parkinson\u2019s disease. Front. Cell Neurosci. 13, 476 (2019).","journal-title":"Front. Cell Neurosci."},{"key":"8602_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24814-0","volume":"8","author":"B Janssen","year":"2018","unstructured":"Janssen, B. et al. Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation. Sci. Rep. 8, 6580 (2018).","journal-title":"Sci. Rep."},{"key":"8602_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-024-01085-7","volume":"14","author":"OM Alzghool","year":"2024","unstructured":"Alzghool, O. M. et al. Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA. EJNMMI Res. 14, 25 (2024).","journal-title":"EJNMMI Res."},{"key":"8602_CR23","doi-asserted-by":"publisher","first-page":"153601212092760","DOI":"10.1177\/1536012120927609","volume":"19","author":"H Zarrinmayeh","year":"2020","unstructured":"Zarrinmayeh, H. & Territo, P. R. Purinergic receptors of the central nervous system: biology, PET ligands, and their applications. Mol. Imaging 19, 1536012120927609 (2020).","journal-title":"Mol. Imaging"},{"key":"8602_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.2967\/jnumed.116.181354","volume":"58","author":"PR Territo","year":"2017","unstructured":"Territo, P. R. et al. Characterization of 11C-GSK1482160 for targeting the P2X7 receptor as a biomarker for neuroinflammation. J. Nucl. Med. 58, 458\u2013465 (2017).","journal-title":"J. Nucl. Med."},{"key":"8602_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/MNM.0000000000000660","volume":"38","author":"J Han","year":"2017","unstructured":"Han, J. et al. Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response. Nucl. Med Commun. 38, 372\u2013382 (2017).","journal-title":"Nucl. Med Commun."},{"key":"8602_CR26","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1021\/acschemneuro.2c00506","volume":"13","author":"G Huang","year":"2022","unstructured":"Huang, G. et al. PET imaging of P2X7 receptor (P2X7R) for neuroinflammation with improved radiosynthesis of tracer [18F]4A in mice and non-human primates. ACS Chem. Neurosci. 13, 3464\u20133476 (2022).","journal-title":"ACS Chem. Neurosci."},{"key":"8602_CR27","doi-asserted-by":"publisher","first-page":"116996","DOI":"10.1016\/j.bmc.2022.116996","volume":"73","author":"G Huang","year":"2022","unstructured":"Huang, G. et al. Hetero-aryl bromide precursor fluorine-18 radiosynthesis and preclinical evaluation of a novel positron emission tomography (PET) tracer [18F]GSK1482160. Bioorg. Med Chem. 73, 116996 (2022).","journal-title":"Bioorg. Med Chem."},{"key":"8602_CR28","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1021\/acschemneuro.4c00067","volume":"15","author":"Y Kong","year":"2024","unstructured":"Kong, Y. et al. Increased cerebral level of P2X7R in a tauopathy mouse model by PET using [18F]GSK1482160. ACS Chem. Neurosci. 15, 2112\u20132120 (2024).","journal-title":"ACS Chem. Neurosci."},{"key":"8602_CR29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4274\/balkanmedj.galenos.2022.2022-7-100","volume":"39","author":"E \u00c7\u0131nar","year":"2022","unstructured":"\u00c7\u0131nar, E., Tel, B. C. & \u015eahin, G. Neuroinflammation in Parkinson\u2019s disease and its treatment opportunities. Balk. Med. J. 39, 318\u2013333 (2022).","journal-title":"Balk. Med. J."},{"key":"8602_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/WNF.0b013e3181342f32","volume":"31","author":"NINDS NET-PD Investigators","year":"2008","unstructured":"NINDS NET-PD Investigators A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results. Clin. Neuropharmacol. 31, 141\u2013150 (2008).","journal-title":"Clin. Neuropharmacol."},{"key":"8602_CR31","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","volume":"74","author":"JJ Gagne","year":"2010","unstructured":"Gagne, J. J. & Power, M. C. Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. Neurology 74, 995\u20131002 (2010).","journal-title":"Neurology"},{"key":"8602_CR32","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.3390\/ijms22052782","volume":"22","author":"J Michael","year":"2021","unstructured":"Michael, J. et al. The leukotriene receptor antagonist montelukast attenuates neuroinflammation and affects cognition in transgenic 5xFAD mice. Int J. Mol. Sci. 22, 2782 (2021).","journal-title":"Int J. Mol. Sci."},{"key":"8602_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02714-z","volume":"20","author":"M Tassan Mazzocco","year":"2023","unstructured":"Tassan Mazzocco, M. et al. Exploring the neuroprotective effects of montelukast on brain inflammation and metabolism in a rat model of quinolinic acid-induced striatal neurotoxicity. J. Neuroinflamm. 20, 34 (2023).","journal-title":"J. Neuroinflamm."},{"key":"8602_CR34","doi-asserted-by":"publisher","first-page":"148498","DOI":"10.1016\/j.brainres.2023.148498","volume":"1817","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Jun Yun, H., Ding, Y., Du, H. & Geng, X. Montelukast sodium protects against focal cerebral ischemic injury by regulating inflammatory reaction via promoting microglia polarization. Brain Res. 1817, 148498 (2023).","journal-title":"Brain Res."},{"key":"8602_CR35","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/ana.26638","volume":"93","author":"B Liu","year":"2023","unstructured":"Liu, B. et al. \u03b22-Adrenoreceptor agonists, Montelukast, and Parkinson disease risk. Ann. Neurol. 93, 1023\u20131028 (2023).","journal-title":"Ann. Neurol."},{"key":"8602_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.30144","volume":"40","author":"J Wallin","year":"2025","unstructured":"Wallin, J., Forsberg, A. & Svenningsson, P. Effects of montelukast on neuroinflammation in Parkinson\u2019s disease: an open label safety and tolerability trial with CSF markers and [11C]PBR28. Pet. Mov. Disord. 40, 739\u2013744 (2025).","journal-title":"Pet. Mov. Disord."},{"key":"8602_CR37","doi-asserted-by":"publisher","first-page":"e2105442","DOI":"10.1002\/advs.202105442","volume":"9","author":"Z Yu","year":"2022","unstructured":"Yu, Z. et al. Microglia regulate blood-brain barrier integrity via MiR-126a-5p\/MMP9 axis during inflammatory demyelination. Adv. Sci.9, e2105442 (2022).","journal-title":"Adv. Sci."},{"key":"8602_CR38","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge, W. M. Drug transport across the blood-brain barrier. J. Cereb. Blood Flow. Metab. 32, 1959\u20131972 (2012).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"8602_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.nbd.2006.06.013","volume":"24","author":"CC Ferrari","year":"2006","unstructured":"Ferrari, C. C. et al. Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra. Neurobiol. Dis. 24, 183\u2013193 (2006).","journal-title":"Neurobiol. Dis."},{"key":"8602_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.parkreldis.2020.11.011","volume":"82","author":"S Lavisse","year":"2021","unstructured":"Lavisse, S. et al. Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging. Parkinson. Relat. Disord. 82, 29\u201336 (2021).","journal-title":"Parkinson. Relat. Disord."},{"key":"8602_CR41","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1007\/s00415-021-10877-z","volume":"269","author":"PF Zhang","year":"2022","unstructured":"Zhang, P. F. & Gao, F. Neuroinflammation in Parkinson\u2019s disease: a meta-analysis of PET imaging studies. J. Neurol. 269, 2304\u20132314 (2022).","journal-title":"J. Neurol."},{"key":"8602_CR42","doi-asserted-by":"publisher","first-page":"105159","DOI":"10.1016\/j.nbd.2020.105159","volume":"147","author":"CF Underwood","year":"2021","unstructured":"Underwood, C. F. & Parr-Brownlie, L. C. Primary motor cortex in Parkinson\u2019s disease: Functional changes and opportunities for neurostimulation. Neurobiol. Dis. 147, 105159 (2021).","journal-title":"Neurobiol. Dis."},{"key":"8602_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D. et al. Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Prim. 7, 47 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"8602_CR44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G. et al. Inflammation and immune dysfunction in Parkinson disease. Nat. Rev. Immunol. 22, 657\u2013673 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"8602_CR45","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1021\/acschemneuro.3c00202","volume":"14","author":"P Ye","year":"2023","unstructured":"Ye, P. et al. Activated microglia in the early stage of a rat model of Parkinson\u2019s disease: revealed by PET-MRI imaging by [18F]DPA-714 targeting TSPO. ACS Chem. Neurosci. 14, 2183\u20132192 (2023).","journal-title":"ACS Chem. Neurosci."},{"key":"8602_CR46","doi-asserted-by":"publisher","first-page":"R335","DOI":"10.1016\/j.cub.2004.04.018","volume":"14","author":"AJ King","year":"2004","unstructured":"King, A. J. The superior colliculus. Curr. Biol. 14, R335\u2013R338 (2004).","journal-title":"Curr. Biol."},{"key":"8602_CR47","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/mds.28453","volume":"36","author":"J Wilson","year":"2021","unstructured":"Wilson, J. et al. Cholinergic basal forebrain volumes predict gait decline in Parkinson\u2019s disease. Mov. Disord. 36, 611\u2013621 (2021).","journal-title":"Mov. Disord."},{"key":"8602_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neurobiolaging.2021.05.023","volume":"106","author":"RC Rea","year":"2021","unstructured":"Rea, R. C. et al. Quantitative EEG and cholinergic basal forebrain atrophy in Parkinson\u2019s disease and mild cognitive impairment. Neurobiol. Aging 106, 37\u201344 (2021).","journal-title":"Neurobiol. Aging"},{"key":"8602_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02490-2","volume":"20","author":"R Jiang","year":"2022","unstructured":"Jiang, R. et al. Associations between grip strength, brain structure, and mental health in > 40,000 participants from the UK Biobank. BMC Med. 20, 286 (2022).","journal-title":"BMC Med"},{"key":"8602_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.neuroscience.2024.05.029","volume":"551","author":"S Kumari","year":"2024","unstructured":"Kumari, S. et al. Gray Matter Atrophy in a 6-OHDA-induced Model of Parkinson\u2019s disease. Neuroscience 551, 217\u2013228 (2024).","journal-title":"Neuroscience"},{"key":"8602_CR51","doi-asserted-by":"publisher","first-page":"121121","DOI":"10.1016\/j.neuroimage.2025.121121","volume":"310","author":"JJ Yun","year":"2025","unstructured":"Yun, J. J., Gailly de Taurines, A., Tai, Y. F. & Haar, S. Anatomical abnormalities suggest a compensatory role of the cerebellum in early Parkinson\u2019s disease. Neuroimage 310, 121121 (2025).","journal-title":"Neuroimage"},{"key":"8602_CR52","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.gaitpost.2019.05.011","volume":"71","author":"OJ Surgent","year":"2019","unstructured":"Surgent, O. J., Dadalko, O. I., Pickett, K. A. & Travers, B. G. Balance and the brain: a review of structural brain correlates of postural balance and balance training in humans. Gait Posture 71, 245\u2013252 (2019).","journal-title":"Gait Posture"},{"key":"8602_CR53","doi-asserted-by":"publisher","first-page":"8406","DOI":"10.1523\/JNEUROSCI.1535-22.2022","volume":"42","author":"J Yoshida","year":"2022","unstructured":"Yoshida, J. et al. Cerebellar contributions to the basal ganglia influence motor coordination, reward processing, and movement vigor. J. Neurosci. 42, 8406\u20138415 (2022).","journal-title":"J. Neurosci."},{"key":"8602_CR54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/brainsci3010101","volume":"3","author":"S Perrey","year":"2013","unstructured":"Perrey, S. Promoting motor function by exercising the brain. Brain Sci. 3, 101\u2013122 (2013).","journal-title":"Brain Sci."},{"key":"8602_CR55","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/jcbfm.2009.111","volume":"29","author":"B Ballanger","year":"2009","unstructured":"Ballanger, B., Jahanshahi, M., Broussolle, E. & Thobois, S. PET functional imaging of deep brain stimulation in movement disorders and psychiatry. J. Cereb. Blood Flow. Metab. 29, 1743\u20131754 (2009).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"8602_CR56","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/ner.12406","volume":"19","author":"V Vedam-Mai","year":"2016","unstructured":"Vedam-Mai, V., Baradaran-Shoraka, M., Reynolds, B. A. & Okun, M. S. Tissue response to deep brain stimulation and microlesion: a comparative study. Neuromodulation 19, 451\u2013458 (2016).","journal-title":"Neuromodulation"},{"key":"8602_CR57","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson, B. I. et al. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34, 521\u2013533 (2002).","journal-title":"Neuron"},{"key":"8602_CR58","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s13311-020-00836-3","volume":"17","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger, J. et al. The leukotriene receptor antagonist Montelukast reduces alpha-synuclein load and restores memory in an animal model of dementia with Lewy bodies. Neurotherapeutics 17, 1061\u20131074 (2020).","journal-title":"Neurotherapeutics"},{"key":"8602_CR59","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1007\/s00259-023-06342-w","volume":"50","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Ankylosing spondylitis PET imaging and quantifications via P2X7 receptor-targeting radioligand [18F]GSK1482160. Eur. J. Nucl. Med Mol. Imaging 50, 3589\u20133601 (2023).","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"8602_CR60","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1177\/1545968315570324","volume":"29","author":"HC Roberts","year":"2015","unstructured":"Roberts, H. C. et al. The association of grip strength with severity and duration of Parkinson\u2019s: a cross-sectional study. Neurorehab. Neural Repair 29, 889\u2013896 (2015).","journal-title":"Neurorehab. Neural Repair"},{"key":"8602_CR61","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bbr.2011.12.007","volume":"230","author":"KE Glajch","year":"2012","unstructured":"Glajch, K. E., Fleming, S. M., Surmeier, D. J. & Osten, P. Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson\u2019s disease. Behav. Brain Res. 230, 309\u2013316 (2012).","journal-title":"Behav. Brain Res."},{"key":"8602_CR62","doi-asserted-by":"publisher","first-page":"8453","DOI":"10.3390\/ijms22168453","volume":"22","author":"T Umeda","year":"2021","unstructured":"Umeda, T., Hatanaka, Y., Sakai, A. & Tomiyama, T. Nasal Rifampicin improves cognition in a mouse model of dementia with Lewy bodies by reducing \u03b1-synuclein oligomers. Int J. Mol. Sci. 22, 8453 (2021).","journal-title":"Int J. Mol. Sci."},{"key":"8602_CR63","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.3390\/molecules26237360","volume":"26","author":"AT Campoy","year":"2021","unstructured":"Campoy, A. T. et al. [18F]Nifene PET\/CT imaging in mice: improved methods and preliminary studies of \u03b14\u03b22* nicotinic acetylcholinergic receptors in transgenic A53T mouse model of \u03b1-synucleinopathy and post-mortem human Parkinson\u2019s disease. Molecules 26, 7360 (2021).","journal-title":"Molecules"},{"key":"8602_CR64","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/jnc.14016","volume":"141","author":"G Becker","year":"2017","unstructured":"Becker, G. et al. Comparative assessment of 6-[18F]fluoro-L-m-tyrosine and 6-[18F]fluoro-L-dopa to evaluate dopaminergic presynaptic integrity in a Parkinson\u2019s disease rat model. J. Neurochem 141, 626\u2013635 (2017).","journal-title":"J. Neurochem"},{"key":"8602_CR65","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1177\/0271678X19864081","volume":"40","author":"D Bertoglio","year":"2020","unstructured":"Bertoglio, D. et al. Validation and noninvasive kinetic modeling of [11C]UCB-J PET imaging in mice. J. Cereb. Blood Flow. Metab. 40, 1351\u20131362 (2020).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"8602_CR66","doi-asserted-by":"publisher","first-page":"4419221","DOI":"10.1155\/2022\/4419221","volume":"2022","author":"EF Halff","year":"2022","unstructured":"Halff, E. F. et al. Evaluation of intraperitoneal [18F]-FDOPA administration for micro-PET imaging in mice and assessment of the effect of subchronic ketamine dosing on dopamine synthesis capacity. Mol. Imaging 2022, 4419221 (2022).","journal-title":"Mol. Imaging"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08602-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08602-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08602-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:48:20Z","timestamp":1757346500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08602-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8602"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08602-x","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"23 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures and animal care were under the supervision of the Institutional Animal Care and Use Committee (IACUC) in the Fifth Affiliated Hospital of Sun Yat-sen University (animal protocol No. #00264).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"1188"}}